RecalledThisWeek Search
High risk Drugs & MedicationsClass II

Macleods Levothyroxine Sodium 150mcg Recall

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufact

Updated February 26, 2026

Levothyroxine Sodium 150 mcg tablets manufactured for Macleods Pharma USA are being recalled because they contain lower active ingredient than labeled, which means thyroid patients may not receive proper treatment.

Is the MACLEODS PHARMA USA, INC recalled? Yes. This product was recalled by FDA on February 26, 2026. Details below.

What is recalled

Levothyroxine Sodium Tablets USP 150 mcg, 1000-tablet bottles, Rx Only. Manufactured for Macleods Pharma USA, Inc., Princeton, NJ. Manufactured by Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Gujarat, India. NDC: 33342-401-44.

Am I affected

You are affected if your prescription bottle shows Levothyroxine Sodium 150 mcg tablets with NDC 33342-401-44 and was dispensed from a pharmacy.

What to do right now

Do not stop taking your thyroid medication. Contact your pharmacy or prescribing doctor immediately with the NDC number (33342-401-44) to confirm whether your prescription is affected and to discuss your next steps, which may include switching to a replacement supply.

The hazard

Subpotent Drug

Brands affected

MACLEODS PHARMA USA, INC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0403-2026
Classification
Class II
Recalled
February 26, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls